Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |